Theratechnologies to Announce Financial Results for the First Quarter of 2017

(firmenpresse) - MONTREAL, QUEBEC -- (Marketwired) -- 03/30/17 -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the first quarter ended February 28, 2017, on Thursday, April 6, 2017, before markets open.

A conference call will be held the same day at 8:30 a.m. (ET) to discuss the results. The call will be hosted by Luc Tanguay, President and Chief Executive Officer. The conference call will be open to questions from financial analysts. Media and other interested individuals are invited to participate in the call on a "listen-only" basis.

The conference call can be accessed by dialling 1-877-223-4471 (North America) or 1- 647-788-4922 (International). The conference call will also be accessible via webcast at . Audio replay of the conference call will be available two hours after the completion of the call and until April 20, 2017, by dialling 1-800-585- 8367 (North America) or 1-416-621-4642 (International) and by entering the playback code 84514052.

About Theratechnologies

Theratechnologies (TSX: TH) is a specialty pharmaceutical company addressing unmet medical needs to promote healthy living and an improved quality of life among HIV patients. Further information about Theratechnologies is available on the Company's website at and on SEDAR at .



Contacts:
Theratechnologies Inc.
Chantal Placais
514.336.7800 ext. 233

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 30.03.2017 - 13:31 Uhr
Sprache: Deutsch
News-ID 533456
Anzahl Zeichen: 0

contact information:
Town:

MONTREAL, QUEBEC

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 171 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Theratechnologies to Announce Financial Results for the First Quarter of 2017"
steht unter der journalistisch-redaktionellen Verantwortung von

Theratechnologies Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review ...

MONTREAL, QUEBEC -- (Marketwired) -- 11/13/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that it was notified today by its partner, TaiMed Biologics, Inc. ("TaiMed"), that the U.S. Food and Drug Administration (&quo ...

Theratechnologies Announces Financial Results for Third Quarter of 2017 ...

MONTREAL, QUEBEC -- (Marketwired) -- 10/05/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2017.Third quarter 2017 financial highlights"With three quarters ...

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab P ...

MONTREAL, QUEBEC -- (Marketwired) -- 10/04/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1 who completed the 24-week P ...

Alle Meldungen von Theratechnologies Inc.